IL129481A0 - Substituted tricyclics - Google Patents

Substituted tricyclics

Info

Publication number
IL129481A0
IL129481A0 IL12948197A IL12948197A IL129481A0 IL 129481 A0 IL129481 A0 IL 129481A0 IL 12948197 A IL12948197 A IL 12948197A IL 12948197 A IL12948197 A IL 12948197A IL 129481 A0 IL129481 A0 IL 129481A0
Authority
IL
Israel
Prior art keywords
substituted tricyclics
tricyclics
substituted
Prior art date
Application number
IL12948197A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL129481A0 publication Critical patent/IL129481A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
IL12948197A 1996-10-30 1997-10-23 Substituted tricyclics IL129481A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2984996P 1996-10-30 1996-10-30
PCT/US1997/019183 WO1998018464A1 (en) 1996-10-30 1997-10-23 Substituted tricyclics

Publications (1)

Publication Number Publication Date
IL129481A0 true IL129481A0 (en) 2000-02-29

Family

ID=21851210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12948197A IL129481A0 (en) 1996-10-30 1997-10-23 Substituted tricyclics

Country Status (26)

Country Link
EP (1) EP0839806B1 (cs)
JP (1) JP2001503055A (cs)
KR (1) KR20000049210A (cs)
CN (1) CN1233176A (cs)
AR (1) AR010050A1 (cs)
AT (1) ATE244703T1 (cs)
AU (1) AU734096B2 (cs)
BR (1) BR9713261A (cs)
CA (1) CA2269203A1 (cs)
CO (1) CO4920250A1 (cs)
CZ (1) CZ136899A3 (cs)
DE (1) DE69723393T2 (cs)
DK (1) DK0839806T3 (cs)
EA (1) EA003992B1 (cs)
ES (1) ES2202560T3 (cs)
ID (1) ID18685A (cs)
IL (1) IL129481A0 (cs)
NO (1) NO314899B1 (cs)
NZ (1) NZ335246A (cs)
PE (1) PE10999A1 (cs)
PL (1) PL332896A1 (cs)
PT (1) PT839806E (cs)
TR (1) TR199900956T2 (cs)
TW (1) TW513428B (cs)
WO (1) WO1998018464A1 (cs)
YU (1) YU19299A (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009978A1 (en) * 1997-08-28 1999-03-04 Eli Lilly And Company Method for treatment of non-rheumatoid athritis
KR20010042307A (ko) 1998-03-31 2001-05-25 시오노 요시히코 피롤로[1,2-a]피라진 sPLA2 억제제
ID23219A (id) * 1998-04-17 2000-03-30 Lilly Co Eli Trisiklik tersubstitusi
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
SK16342000A3 (sk) 1998-05-01 2002-04-04 Eli Lilly And Company Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy
US6472389B1 (en) 1998-05-21 2002-10-29 Shionogi & Co., Ltd. Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect
AU6004799A (en) 1998-10-14 2000-05-01 Shionogi & Co., Ltd. Remedies or preventives for ischemic reflow failure
DE69910432D1 (de) * 1998-12-22 2003-09-18 Lilly Co Eli Substituierte pyrroloindole
US6703385B1 (en) 1999-07-19 2004-03-09 Shionogi & Co., Ltd. Tricyclic compounds having sPLA2-inhibitory activities
WO2001009130A1 (en) 1999-08-02 2001-02-08 Shionogi & Co., Ltd. TRICYCLIC COMPOUNDS HAVING sPLA2-INHIBITORY ACTIVITIES
JP4623483B2 (ja) 1999-08-23 2011-02-02 塩野義製薬株式会社 sPLA2阻害作用を有するピロロトリアジン誘導体
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
US6756376B1 (en) 1999-11-15 2004-06-29 Shionogi & Co., Ltd. Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities
JP2003519198A (ja) * 2000-01-06 2003-06-17 イーライ・リリー・アンド・カンパニー 炎症性疾患および呼吸器疾患の処置のための併用療法
US6967200B2 (en) 2000-06-29 2005-11-22 Shionogi & Co., Ltd. Remedies for cirrhosis
US7026318B2 (en) 2000-06-29 2006-04-11 Shionogi & Co., Ltd. Compounds exhibiting X-type sPLA2 inhibiting effect
US6872743B2 (en) 2000-12-18 2005-03-29 Eli Lilly And Company sPLA2 inhibitors
TWI314457B (cs) 2001-03-19 2009-09-11 Shionogi & Co
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
WO2006046779A1 (ja) 2004-10-29 2006-05-04 Zeria Pharmaceutical Co., Ltd. カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩
WO2016203468A1 (en) * 2015-06-15 2016-12-22 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
CN112409493B (zh) * 2020-08-12 2022-09-30 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用
US12440370B2 (en) 2020-10-21 2025-10-14 Purewick Corporation Apparatus with compressible casing for receiving discharged urine
US12257174B2 (en) 2020-10-21 2025-03-25 Purewick Corporation Fluid collection assemblies including at least one of a protrusion or at least one expandable material
US12208031B2 (en) 2020-10-21 2025-01-28 Purewick Corporation Adapters for fluid collection devices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479391A (en) * 1966-10-03 1969-11-18 Squibb & Sons Inc Delta**3,14-17alpha-hydroxy-norprogesterone and esters
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors

Also Published As

Publication number Publication date
EP0839806A1 (en) 1998-05-06
DK0839806T3 (da) 2003-10-27
EA003992B1 (ru) 2003-12-25
EP0839806B1 (en) 2003-07-09
ES2202560T3 (es) 2004-04-01
YU19299A (sh) 2000-03-21
ATE244703T1 (de) 2003-07-15
TR199900956T2 (xx) 1999-07-21
AU5149498A (en) 1998-05-22
WO1998018464A1 (en) 1998-05-07
DE69723393D1 (de) 2003-08-14
CZ136899A3 (cs) 1999-09-15
ID18685A (id) 1998-04-30
JP2001503055A (ja) 2001-03-06
NO314899B1 (no) 2003-06-10
AU734096B2 (en) 2001-06-07
DE69723393T2 (de) 2004-06-09
TW513428B (en) 2002-12-11
NZ335246A (en) 2001-09-28
AR010050A1 (es) 2000-05-17
CN1233176A (zh) 1999-10-27
CO4920250A1 (es) 2000-05-29
PE10999A1 (es) 1999-02-10
PT839806E (pt) 2003-11-28
KR20000049210A (ko) 2000-07-25
NO991831D0 (no) 1999-04-16
NO991831L (no) 1999-06-21
EA199900305A1 (ru) 1999-12-29
BR9713261A (pt) 2000-03-28
CA2269203A1 (en) 1998-05-07
PL332896A1 (en) 1999-10-25

Similar Documents

Publication Publication Date Title
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
IL129481A0 (en) Substituted tricyclics
ZA97171B (en) Novel use
SG60040A1 (en) Novel heterroaryl-oxazolidinones
PL327037A1 (en) Novel combination
DE59705192D1 (en) Lcp-blends
DE59711450D1 (en) Arylalkanoylpyridazine
IL129483A0 (en) Substituted tricyclics
DE59700372D1 (en) Blockcopolymere
HU9700446D0 (en) Oilsuspension-concentrate
IL129484A0 (en) Substituted tricyclics
DE59707730D1 (en) Peripheralpumpe
DE59704086D1 (en) Twin-dualmode-filter
DE59703905D1 (en) Linearmotorgetriebene transportanlage
AU131131S (en) Handleset
GB9606016D0 (en) Novel use
AU131132S (en) Handleset
EP0895545A4 (en) A NEW PROTEIN, TRAF 6
ZA972591B (en) Substituted 1-methyl-3-benzyluracils
ZA9711235B (en) Substituted pyrazol-3-ylbenzazoles
DE59702027D1 (en) Bragg-modulator
DE59703023D1 (en) Cyclopeptidderivate
AU131198S (en) Handleset
AU131199S (en) Handleset
DE59709914D1 (en) Substituierte aromatische phosphonsäurederivate